Connecting researchers, industry, and patient groups to accelerate the development of individualized treatments.
Through targeted programs and resources, N1C helps researchers, clinicians, and patient communities work together to advance individualized therapies. Its offerings—from cross-sector workgroups to global registries—equip the field to solve challenges and move discoveries forward.
The N=1 Collaborative (N1C) is a global nonprofit network fostering the development of interventional genetic medicines for patients with ultra-rare genetic conditions. N1C serves as an ecosystem enabler — convening stakeholders across academia, industry, and patient groups to share knowledge, coordinate efforts, and accelerate the translation of individualized therapies into an organized and accessible standard of care.
To sign up and qualify, you must have done one of the following within the past year:
Driven by robust workflows, Danaher experts will help you personalize your lab by providing solution offerings to meet your needs.
Discounts are available with further savings possible depending on your new launch requirements.